Clinical Trials Browser

Phase 3 × Interventional × revumenib × Clear all

NCT07211958 2026-05-20

REVEAL-ND NPM1

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06652438 2025-04-04

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute